Among individual compounds, oxymatrine inhibits CRC liver metastasis via dual mechanisms: by suppressing the leucine-rich pentatricopeptide repeat containing (LRPPRC) protein, promoting Parkin mitochondrial translocation, and inhibiting the NLRP3 inflammasome. The gene discussed is PRKN; the disease is colorectal carcinoma.